140 related articles for article (PubMed ID: 36720769)
1. A multi-centre retrospective study of Nocardia speciation and antimicrobial susceptibility in Queensland, Australia.
Sim BZ; Aaron L; Coulter C; Parkes-Smith J; Badrick T; May K; Armstrong M; Hendry S; Sundac L; Dang L; Ho J; Hanson J; Smith S; Choong K; Henderson AH; Bursle E
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):339-345. PubMed ID: 36720769
[TBL] [Abstract][Full Text] [Related]
2. Identification and antimicrobial susceptibility of referred
Yeoh K; Globan M; Naimo P; Williamson DA; Lea K; Bond K
J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35976092
[No Abstract] [Full Text] [Related]
3. Nocardia species distribution and antimicrobial susceptibility within Australia.
O'Brien A; Hart J; Higgins A; Arthur I; Lee GH; Leung M; Kennedy K; Bradbury S; Foster S; Warren S; Korman TM; Abbott IJ; Heney C; Bletchley C; Warner M; Wells N; Wilson D; Varadhan H; Stevens R; Lahra M; Newton P; Maley M; van Hal S; Ingram PR
Intern Med J; 2024 Apr; 54(4):613-619. PubMed ID: 37929813
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015.
Lebeaux D; Bergeron E; Berthet J; Djadi-Prat J; Mouniée D; Boiron P; Lortholary O; Rodriguez-Nava V
Clin Microbiol Infect; 2019 Apr; 25(4):489-495. PubMed ID: 29933049
[TBL] [Abstract][Full Text] [Related]
5. Nocardiosis at the turn of the century.
Minero MV; Marín M; Cercenado E; Rabadán PM; Bouza E; Muñoz P
Medicine (Baltimore); 2009 Jul; 88(4):250-261. PubMed ID: 19593231
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
Tan YE; Chen SC; Halliday CL
J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
[TBL] [Abstract][Full Text] [Related]
7. Nocardiosis: 7-year experience at an Australian tertiary hospital.
Paige EK; Spelman D
Intern Med J; 2019 Mar; 49(3):373-379. PubMed ID: 30091232
[TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China.
Li J; Shen H; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
Jpn J Infect Dis; 2022 Jan; 75(1):31-35. PubMed ID: 34053953
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Lao CK; Tseng MC; Chiu CH; Chen NY; Chen CH; Chung WH; Liu TP; Lu JJ; Lai HC; Yang LY; Lee CH; Wu TS
J Formos Med Assoc; 2022 Oct; 121(10):2109-2122. PubMed ID: 35811270
[TBL] [Abstract][Full Text] [Related]
10. Infection with Nocardia species in Queensland. A review of 102 clinical isolates.
Georghiou PR; Blacklock ZM
Med J Aust; 1992 May; 156(10):692-7. PubMed ID: 1620016
[TBL] [Abstract][Full Text] [Related]
11. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.
Huang L; Chen X; Xu H; Sun L; Li C; Guo W; Xiang L; Luo G; Cui Y; Lu B
Diagn Microbiol Infect Dis; 2019 Jun; 94(2):165-172. PubMed ID: 30679058
[TBL] [Abstract][Full Text] [Related]
12. Species distribution and susceptibility of Nocardia isolates in New Zealand 2002-2021.
McKinney WP; Smith MR; Roberts SA; Morris AJ
Pathology; 2023 Aug; 55(5):680-687. PubMed ID: 37277236
[TBL] [Abstract][Full Text] [Related]
13. The species distribution and antimicrobial resistance profiles of Nocardia species in China: A systematic review and meta-analysis.
Wang C; Sun Q; Yan J; Liao X; Long S; Zheng M; Zhang Y; Yang X; Shi G; Zhao Y; Wang G; Pan J
PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011432. PubMed ID: 37428800
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations and outcome of nocardiosis and antimicrobial susceptibility of Nocardia species in southern Taiwan, 2011-2021.
Yang CH; Kuo SF; Chen FJ; Lee CH
J Microbiol Immunol Infect; 2023 Apr; 56(2):382-391. PubMed ID: 36456442
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece.
Maraki S; Mavromanolaki VE; Kasimati A; Stafylaki D; Scoulica E
Acta Microbiol Immunol Hung; 2023 Sep; 70(3):239-245. PubMed ID: 37459246
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Analysis of Antimicrobial Susceptibility Profiles of
Hamdi AM; Fida M; Deml SM; Abu Saleh OM; Wengenack NL
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818815
[No Abstract] [Full Text] [Related]
19. Epidemiology and Antimicrobial Resistance Profiles of the
Wang H; Zhu Y; Cui Q; Wu W; Li G; Chen D; Xiang L; Qu J; Shi D; Lu B
Microbiol Spectr; 2022 Apr; 10(2):e0156021. PubMed ID: 35234511
[TBL] [Abstract][Full Text] [Related]
20. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
Wei M; Xu X; Yang J; Wang P; Liu Y; Wang S; Yang C; Gu L
BMC Microbiol; 2021 Dec; 21(1):342. PubMed ID: 34903163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
